MX2023014630A - Activadores de dimetoxifenilalquilamina de receptores de serotonina. - Google Patents
Activadores de dimetoxifenilalquilamina de receptores de serotonina.Info
- Publication number
- MX2023014630A MX2023014630A MX2023014630A MX2023014630A MX2023014630A MX 2023014630 A MX2023014630 A MX 2023014630A MX 2023014630 A MX2023014630 A MX 2023014630A MX 2023014630 A MX2023014630 A MX 2023014630A MX 2023014630 A MX2023014630 A MX 2023014630A
- Authority
- MX
- Mexico
- Prior art keywords
- sub
- dimethoxyphenylalkylamine
- activators
- serotonin receptors
- formula
- Prior art date
Links
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 title 1
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 title 1
- 239000012190 activator Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000004630 mental health Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/52—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/64—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
- C07C217/66—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain
- C07C217/70—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
- C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
- C07C321/24—Thiols, sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
- C07C321/28—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
- C07C381/10—Compounds containing sulfur atoms doubly-bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163208391P | 2021-06-08 | 2021-06-08 | |
| US202163241662P | 2021-09-08 | 2021-09-08 | |
| PCT/US2022/032715 WO2022261240A2 (en) | 2021-06-08 | 2022-06-08 | Dimethoxyphenylalkylamine activators of serotonin receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023014630A true MX2023014630A (es) | 2024-01-30 |
Family
ID=84426423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023014630A MX2023014630A (es) | 2021-06-08 | 2022-06-08 | Activadores de dimetoxifenilalquilamina de receptores de serotonina. |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11926574B2 (enExample) |
| EP (1) | EP4351548A4 (enExample) |
| JP (1) | JP2024520832A (enExample) |
| KR (1) | KR20240019157A (enExample) |
| AU (1) | AU2022288926A1 (enExample) |
| BR (1) | BR112023025599A2 (enExample) |
| CA (1) | CA3216096A1 (enExample) |
| CL (1) | CL2023003662A1 (enExample) |
| IL (1) | IL309074A (enExample) |
| MX (1) | MX2023014630A (enExample) |
| WO (1) | WO2022261240A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023539113A (ja) | 2020-08-18 | 2023-09-13 | サイビン アイアールエル リミテッド | フェネチルアミン誘導体、組成物およびその使用方法 |
| JP2024520832A (ja) | 2021-06-08 | 2024-05-24 | エンセオジェニックス バイオサイエンシズ， インコーポレイテッド | セロトニン受容体のジメトキシフェニルアルキルアミン活性化剤 |
| CA3242479A1 (en) | 2021-12-27 | 2023-07-06 | Atai Therapeutics, Inc. | AMINOTERALINE SEROTONIN RECEPTOR ACTIVATORS |
| JP2026513655A (ja) * | 2022-10-28 | 2026-04-30 | サイビン アイアールエル リミテッド | フェネチルアミン化合物、組成物、及び使用方法 |
| WO2024124056A1 (en) * | 2022-12-07 | 2024-06-13 | Entheogenix Biosciences, Inc. | Novel sulfoximine activators of serotonin receptors |
| EP4637735A1 (en) * | 2022-12-22 | 2025-10-29 | ATAI Therapeutics, Inc. | Dimethoxyphenyl heteroaromatic alkylamine activators of serotonin receptors |
| EP4637736A1 (en) * | 2022-12-22 | 2025-10-29 | ATAI Therapeutics, Inc. | Prodrugs of dimethoxyphenylalkylamine activators of serotonin receptors |
| US12343319B2 (en) | 2023-05-01 | 2025-07-01 | Atai Therapeutics, Inc. | Compositions and methods for treatment of diseases and disorders |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6045180B2 (ja) | 1977-05-17 | 1985-10-08 | 第一製薬株式会社 | ２−アミノテトラリン誘導体 |
| ZA903906B (en) * | 1989-05-25 | 1992-02-26 | Takeda Chemical Industries Ltd | Benzocycloalkane derivatives and production thereof |
| AU632809B2 (en) * | 1989-05-25 | 1993-01-14 | Takeda Chemical Industries Ltd. | Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof |
| FR2691145A1 (fr) * | 1992-05-18 | 1993-11-19 | Inst Nat Sante Rech Med | Nouveaux dérivés de la dihydroxybenzylamine, leur préparation et les compositions pharmaceutiques qui les contiennent. |
| US5807897A (en) | 1996-03-01 | 1998-09-15 | Zeneca Limited | Aminotetralin derivative and compositions and method of use thereof |
| US6225352B1 (en) | 1996-08-14 | 2001-05-01 | Warner-Lambert Company | Low molecular weight dendritic compounds as pharmaceutical agents |
| NZ510988A (en) | 1998-10-07 | 2005-01-28 | Ortho Mcneil Pharm Inc | N-aralkylaminotetralins useful as ligands for the neuropeptide Y5 receptor |
| HUP0202143A3 (en) | 1999-07-28 | 2003-12-29 | Ortho Mcneil Pharm Inc | Amine and amide derivatives as ligands for the neuropeptide y y5 receptor pharmaceutical compositions containing them and their use |
| DE10007948A1 (de) | 2000-02-22 | 2001-09-06 | Wella Ag | Mittel zur Färbung von Fasern |
| FR2809396B1 (fr) | 2000-05-24 | 2005-10-14 | Centre Nat Rech Scient | Nouvelles molecules possedant une activite calcimimetique et leur mode de preparation |
| ES2566056T3 (es) | 2001-03-29 | 2016-04-08 | Eli Lilly And Company | N-(2-ariletil)bencilaminas como antagonistas del receptor 5-HT6 |
| US20050152858A1 (en) | 2003-07-11 | 2005-07-14 | Isp Investments Inc. | Solubilizing agents for active or functional organic compounds |
| US20070196395A1 (en) | 2003-12-12 | 2007-08-23 | Mackerell Alexander | Immunomodulatory compounds that target and inhibit the py'binding site of tyrosene kinase p56 lck sh2 domain |
| US7598255B2 (en) | 2005-08-04 | 2009-10-06 | Janssen Pharmaceutica Nv | Pyrimidine compounds as serotonin receptor modulators |
| US9101613B2 (en) | 2006-02-15 | 2015-08-11 | Neurim Pharmaceuticals (1991) Ltd. | Methods for treating neurological disease |
| MX2008015843A (es) | 2006-06-20 | 2009-01-09 | Hoffmann La Roche | Derivados de tetralina e indano y usos de los mismos. |
| US20080248511A1 (en) | 2007-03-26 | 2008-10-09 | Promega Corporation | Methods to quench light from optical reactions |
| CA2686994A1 (en) | 2007-05-11 | 2008-11-20 | Mpex Pharmaceuticals, Inc. | Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof |
| BRPI0919920A2 (pt) | 2008-10-22 | 2016-02-16 | Acucela Inc | compostos para tratamento de doenças e desordens oftálmicas |
| US20120283298A1 (en) | 2009-10-16 | 2012-11-08 | Albert Michael Crider | Methods for treating memory impairment |
| EP2418196A1 (en) | 2010-07-29 | 2012-02-15 | IMTM GmbH | Dual alanyl-aminopeptidase and dipeptidyl-peptidase IV inhibitors |
| GB201409516D0 (en) * | 2014-05-29 | 2014-07-16 | Randox Lab Ltd | Immunoassay for compounds of the NBOMe family |
| US10454900B2 (en) | 2015-09-25 | 2019-10-22 | Mcafee, Llc | Remote authentication and passwordless password reset |
| WO2018094005A1 (en) | 2016-11-16 | 2018-05-24 | The General Hospital Corporation | Myeloperoxidase imaging agents |
| EP3700935A4 (en) | 2017-10-25 | 2021-08-04 | University Of South Florida | INGREDIENT-INDUCED ACTIVATION OF THE REELIN SIGNALING SYSTEM |
| CA3079819C (en) | 2017-11-06 | 2023-03-14 | Acelot, Inc. | Small molecule drugs and related methods for treatment of diseases related to a.beta.42 oligomer formation |
| WO2019099402A1 (en) | 2017-11-14 | 2019-05-23 | Rutgers, The State University Of New Jersey | Therapeutic compounds and methods to treat infection |
| AU2018379992B2 (en) | 2017-12-05 | 2022-07-21 | Sunovion Pharmaceuticals Inc. | Nonracemic mixtures and uses thereof |
| EP3841085B1 (en) * | 2018-08-22 | 2026-05-06 | University Of Technology Sydney | Nbome test |
| US12318357B2 (en) | 2019-08-02 | 2025-06-03 | Acelot, Inc. | Small molecule drugs and related methods for treatment of diseases related to TDP-43, alpha-synuclein, huntingtin's protein and tau protein oligomer formation |
| US11660305B2 (en) | 2019-11-19 | 2023-05-30 | Turtle Bear Holdings, Llc | Tryptamine compositions for enhancing neurite outgrowth |
| US12534425B2 (en) | 2020-06-29 | 2026-01-27 | Gilgamesh Pharmaceuticals, Inc. | Phenalkylamines and methods of treating mood disorders |
| DK4172145T3 (da) | 2020-06-30 | 2026-07-20 | Reunion Neuroscience Inc | Tryptamin-prodrugs som serotonin-receptor-aktivatorer til behandling af f.eks. depression |
| JP2024512796A (ja) | 2021-04-01 | 2024-03-19 | テラン バイオサイエンシーズ インク． | サイケデリック薬およびセロトニン受容体調節因子に関する方法と組成物 |
| CA3217737A1 (en) | 2021-05-11 | 2022-11-17 | Jason WALLACH | Selective, partial, and arrestin-biased 5-ht2a agonists with utility in various disorders |
| JP2024520832A (ja) | 2021-06-08 | 2024-05-24 | エンセオジェニックス バイオサイエンシズ， インコーポレイテッド | セロトニン受容体のジメトキシフェニルアルキルアミン活性化剤 |
| WO2022261263A1 (en) | 2021-06-08 | 2022-12-15 | Gilgamesh Pharmaceuticals, Inc. | Methods of treating neuropsychiatric disorders |
| MX2024007220A (es) | 2021-12-15 | 2024-08-27 | Delix Therapeutics Inc | Psicoplastogenos de pirrolidina fusionada y sus usos. |
| CA3242479A1 (en) | 2021-12-27 | 2023-07-06 | Atai Therapeutics, Inc. | AMINOTERALINE SEROTONIN RECEPTOR ACTIVATORS |
| WO2024124056A1 (en) | 2022-12-07 | 2024-06-13 | Entheogenix Biosciences, Inc. | Novel sulfoximine activators of serotonin receptors |
| EP4637736A1 (en) | 2022-12-22 | 2025-10-29 | ATAI Therapeutics, Inc. | Prodrugs of dimethoxyphenylalkylamine activators of serotonin receptors |
| EP4637735A1 (en) | 2022-12-22 | 2025-10-29 | ATAI Therapeutics, Inc. | Dimethoxyphenyl heteroaromatic alkylamine activators of serotonin receptors |
| WO2024192150A2 (en) | 2023-03-16 | 2024-09-19 | Atai Therapeutics Inc. | 3-alkylamine indole activators of serotonin receptors |
| US12343319B2 (en) | 2023-05-01 | 2025-07-01 | Atai Therapeutics, Inc. | Compositions and methods for treatment of diseases and disorders |
-
2022
- 2022-06-08 JP JP2023576035A patent/JP2024520832A/ja active Pending
- 2022-06-08 US US17/835,764 patent/US11926574B2/en active Active
- 2022-06-08 CA CA3216096A patent/CA3216096A1/en active Pending
- 2022-06-08 BR BR112023025599A patent/BR112023025599A2/pt unknown
- 2022-06-08 KR KR1020237044143A patent/KR20240019157A/ko active Pending
- 2022-06-08 MX MX2023014630A patent/MX2023014630A/es unknown
- 2022-06-08 AU AU2022288926A patent/AU2022288926A1/en active Pending
- 2022-06-08 EP EP22820982.1A patent/EP4351548A4/en active Pending
- 2022-06-08 IL IL309074A patent/IL309074A/en unknown
- 2022-06-08 WO PCT/US2022/032715 patent/WO2022261240A2/en not_active Ceased
-
2023
- 2023-12-06 CL CL2023003662A patent/CL2023003662A1/es unknown
-
2024
- 2024-02-07 US US18/435,857 patent/US12351537B2/en active Active
-
2025
- 2025-05-22 US US19/216,245 patent/US20250282712A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022288926A1 (en) | 2023-10-19 |
| CL2023003662A1 (es) | 2024-05-03 |
| WO2022261240A2 (en) | 2022-12-15 |
| US12351537B2 (en) | 2025-07-08 |
| US11926574B2 (en) | 2024-03-12 |
| CA3216096A1 (en) | 2022-12-15 |
| WO2022261240A3 (en) | 2023-01-05 |
| EP4351548A4 (en) | 2025-04-30 |
| US20230138118A1 (en) | 2023-05-04 |
| US20250282712A1 (en) | 2025-09-11 |
| US20240294461A1 (en) | 2024-09-05 |
| BR112023025599A2 (pt) | 2024-02-20 |
| JP2024520832A (ja) | 2024-05-24 |
| IL309074A (en) | 2024-02-01 |
| KR20240019157A (ko) | 2024-02-14 |
| EP4351548A2 (en) | 2024-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2022261240A3 (en) | Dimethoxyphenylalkylamine activators of serotonin receptors | |
| MX2023012361A (es) | Inhibidor de parp que contiene estructura de piperazina, metodo de preparacion del mismo y uso farmaceutico del mismo. | |
| MX2023012971A (es) | Agonistas del receptor de orexina y sus usos. | |
| WO2005063745A3 (en) | Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof | |
| AR062536A1 (es) | Acilanilidas sustituidas y composicion farmaceutica | |
| DK1697370T3 (da) | Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer | |
| WO2024192150A3 (en) | 3-alkylamine indole activators of serotonin receptors | |
| CY1108690T1 (el) | Υποκατεστημενες ν-αρυλοπυρρολιδινες ως επιλεκτικοι διαμορφωτες υποδοχεα ανδρογονων | |
| IL176110A0 (en) | Azabicyclic heterocycles as cannabinoid receptor modulators | |
| HRP20090281T1 (hr) | 1,2,3,4-tetrasubstituirani indol za liječenje respiratornih bolesti | |
| CY1110014T1 (el) | Παραγωγα τετραϋδροκαρβαζολιου χρησιμα ως τροποποιητες υποδοχεα ανδρογονων (sarm) | |
| EA200601350A1 (ru) | Азотсодержащие гетероциклические производные и их фармацевтические применения | |
| JP2009541223A5 (enExample) | ||
| PA8591701A1 (es) | Derivados de pirrolopirimidina | |
| NO20091938L (no) | 7,8-dihydro-1,6-naftyridin-5(6H)-oner og relaterte bicykliske forbindelser som inhibitorer av dipeptidyl-peptidaser IV og metoder | |
| GEAP202516634A (en) | Heteroaryl compounds for the treatment of pain | |
| TNSN07145A1 (fr) | Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique | |
| MX2007004183A (es) | Derivados de benzoimidazol utiles como agentes antiproliferacion. | |
| TW200612936A (en) | Indole derivatives | |
| MXPA06009475A (es) | Derivados de quinazolina y usos terapeuticos de los mismos. | |
| MX2023015074A (es) | Agonistas de sulfonamidas del receptor de orexina y sus usos. | |
| WO2023129958A3 (en) | Nitric oxide releasing prodrugs of mda and mdma | |
| SE9903997D0 (sv) | New compounds | |
| EA200501703A1 (ru) | Применение производных азетидинкарбоксамида в терапии | |
| MX2008001606A (es) | Piperazinas substituidas como antagonistas de receptor de glutamato metabotropico. |